World's Best Scientists 2026 revealed!
Giovanni Di Perri

Giovanni Di Perri

D-Index & Metrics

Biology and Biochemistry

D-Index
58
Citations
13724
World Ranking
13076
National Ranking
393

Giovanni Di Perri publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Giovanni Di Perri sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 560 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Giovanni Di Perri D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Giovanni Di Perri sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 58 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Giovanni Di Perri is affiliated with the University of Turin in Italy and has a research focus primarily in the field of medicine, with significant contributions to infectious diseases. Their work spans several subfields, including infectious diseases, epidemiology, molecular biology, public health, and environmental and occupational health. Additionally, some research intersects with plant science.

The scientist has produced a notable body of work in topics relating to SARS-CoV-2 and COVID-19 research, including COVID-19 clinical research studies and SARS-CoV-2 detection and testing. Other research topics include antibiotic resistance in bacteria, tuberculosis research and epidemiology, plant virus research studies, and mosquito-borne diseases and control.

Giovanni Di Perri has published research in various scientific venues. Frequent publication platforms include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Microbiology and Infection
  • Eurosurveillance
  • International Journal of Infectious Diseases
  • PLoS ONE

Several recent papers illustrate the scope of their work. These include:

  • "Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities," 2020, The Journal of Infectious Diseases
  • "Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020," 2020, Eurosurveillance
  • "Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming 'collateral effect,'" 2020, Journal of Global Antimicrobial Resistance
  • "Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing," 2021, International Journal of Environmental Research and Public Health
  • "COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study," 2020, PLoS ONE

Collaborative efforts are a significant aspect of Di Perri's research. Frequent coauthors include:

  • Maria Rosaria Capobianchi
  • Giuseppe Ippolito
  • Francesco Messina
  • Concetta Castilletti
  • Martina Rueca

Best Publications

  • Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

    Antonella Castagna;Franco Maggiolo;Giovanni Penco;David Wright

  • 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge.

    Tommaso Lupia;Silvia Scabini;Simone Mornese Pinna;Giovanni Di Perri

  • Risk Factors for Tuberculosis in HIV-lnfected Persons: A Prospective Cohort Study

    Giorgio Antonucci;Enrico Girardi;Mario C. Raviglione;Giuseppe Ippolito

  • Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19.

    Savino Sciascia;Franco Aprà;Alessandra Baffa;Simone Baldovino

  • NATURALLY ACQUIRED-IMMUNITY TO PLASMODIUM-FALCIPARUM

    Karen P. Day;Kevin Marsh

  • Consensus document on controversial issues for the treatment of infections of the central nervous system: bacterial brain abscesses.

    Massimo Arlotti;Paolo Grossi;Federico Pea;Giustino Tomei

  • Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations.

    Sonia Rodríguez-Nóvoa;Pablo Labarga;Antonio D'avolio;Pablo Barreiro

  • Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?

    Giovanni Di Perri;Stefano Bonora

  • Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

    Alessandro Cozzi-Lepri;Marc Noguera-Julian;Francesca Di Giallonardo;Rob Schuurman

  • Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase 3b, non-inferiority trial

    Jose R Arribas;Gilles Pialoux;Joseph Gathe;Giovanni Di Perri

  • A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma.

    Alessandra Ariaudo;Fabio Favata;Amedeo De Nicolò;Marco Simiele

  • Transbronchial biopsy in the diagnosis of pulmonary infiltrates in immunocompromised patients.

    Angelo Cazzadori;Giovanni Di Perri;Giuseppe Todeschini;Roberto Luzzati

  • New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma.

    Silvia De Francia;Antonio D’Avolio;Francesca De Martino;Elisa Pirro

  • Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.

    Francesco Perrone;Maria Carmela Piccirillo;Paolo Antonio Ascierto;Carlo Salvarani

  • HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients

    Antonio D’Avolio;Marco Siccardi;Mauro Sciandra;Baietto Lorena

  • Genetic Variants of ABCC10, a Novel Tenofovir Transporter, Are Associated With Kidney Tubular Dysfunction

    Sudeep P. Pushpakom;Sudeep P. Pushpakom;Neill J. Liptrott;Neill J. Liptrott;Sonia Rodríguez-Nóvoa;Pablo Labarga

  • Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients.

    Stefano Cosma;Andrea R. Carosso;Jessica Cusato;Fulvio Borella

  • Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial.

    Vicente Soriano;Keikawus Arasteh;Horacio Migrone;Thomas Lutz

  • Impact of Highly Active Antiretroviral Therapy on the Presenting Features and Outcome of Patients with Acquired Immunodeficiency Syndrome-Related Kaposi Sarcoma

    Guglielmo Nasti;Ferdinando Martellotta;Massimiliano Berretta;Maurizio Mena

  • Comparative histopathological study of pulmonary tuberculosis in human immunodeficiency virus-infected and non-infected patients

    G. Di Perri;A. Cazzadori;S. Vento;S. Bonora

Frequent Co-Authors

Carlo Federico Perno
Carlo Federico Perno University of Milan
Massimo Andreoni
Massimo Andreoni University of Rome Tor Vergata
Andrea Antinori
Andrea Antinori Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
David Back
David Back University of Liverpool
Adriano Lazzarin
Adriano Lazzarin Vita-Salute San Raffaele University
Massimo Galli
Massimo Galli University of Milan
Marta Boffito
Marta Boffito Imperial College London
Saye Khoo
Saye Khoo University of Liverpool
Giuliano Rizzardini
Giuliano Rizzardini ASST Fatebenefratelli Sacco
Antonella d'Arminio Monforte
Antonella d'Arminio Monforte University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry opens the door to numerous career opportunities—many of which can be accessed through flexible, accredited online degrees. For those interested in nutrition sciences, pursuing a master degree in nutrition online is a strategic choice. These programs offer advanced coursework and research opportunities, ideal for those seeking roles in public health, private practice, or research.

If clinical or diagnostic technologies appeal to you, consider an education as an ultrasound technician. Accredited ultrasound tech school programs online allow you to study imaging techniques from home, often paired with real-world clinical practice.

For quick entry into medical imaging, 1 year radiology tech programs online provide foundational skills needed for hospital or clinic settings. These programs, at the associate level, are designed to get you workforce-ready in less time.

Finally, if dietetics and nutrition guidance is your passion, compare the top dietetics masters programs available online. A master’s in this field enhances career prospects, especially in clinical nutrition, wellness, or allied health.

Best Scientists Citing Giovanni Di Perri

Trending Scientists

Recently Published Articles